- Full Text
- Scholarly Journal
An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast*

Preview author details
; 
Preview author details
; 
Preview author details
; 
Preview author details
; 
Preview author details
; et al.
Current Medical Research and Opinion

Preview publication details
; Newbury Vol. 24, Iss. 5, (May 2008): 1529-38.